CYBN Competitors & Alternatives
Compare Cybin Inc. with similar stocks in the same industry
Pharmaceutical Preparations
CYBN
Main Stock$8.28
Tradestie Score
58
Market Cap
$150.63M
Analyst Upside
+479.7%
Top Competitors
553 stocks in Pharmaceutical Preparations| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LLY
Eli Lilly & Co.
|
$887.09
|
$739.95B | 39.1 | 54 | Compare |
|
JNJ
Johnson & Johnson
|
$241.87
|
$448.07B | 21.7 | 60 | Compare |
|
ABBV
ABBVIE INC.
|
$212.46
|
$431.71B | 89.5 | 56 | Compare |
|
NVO
Novo-Nordisk A/S
|
$35.14
|
$262.92B | 10.2 | 53 | Compare |
|
AZN
AstraZeneca PLC
|
$193.77
|
$261.56B | 28.0 | 64 | Compare |
|
NVS
Novartis AG
|
$150.28
|
$254.99B | 20.9 | 53 | Compare |
|
ABT
Abbott Laboratories
|
$101.85
|
$232.30B | 28.1 | 61 | Compare |
|
MRK
Merck & Co., Inc.
|
$117.67
|
$225.13B | 16.3 | 65 | Compare |
|
PFE
Pfizer Inc.
|
$27.63
|
$154.70B | 20.3 | 65 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$46.76
|
$121.27B | 19.9 | 63 | Compare |
More CYBN Analysis
Data updated: Mar 30, 2026 | Industry: Pharmaceutical Preparations (SIC 2834)
553 stocks in this industry